Research Topics
Genomes and Genes
| Goran K HanssonSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Inflammatory mechanisms in atherosclerosisG K Hansson
Karolinska Institutet, Center for Molecular Medicine L8 03, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
J Thromb Haemost 7:328-31. 2009..Inflammatory markers are already used to monitor the disease process and anti-inflammatory therapy may be useful to control disease activity...
Medicine. LIGHT hits the liverGoran K Hansson
Department of Medicine and Center for Molecular Medicine, Karolinska Institute, Stockholm, SE-17176, Sweden
Science 316:206-7. 2007
Atherosclerosis--an immune disease: The Anitschkov Lecture 2007Goran K Hansson
Center for Molecular Medicine and Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Atherosclerosis 202:2-10. 2009..Intensified inflammatory activation may lead to local proteolysis, plaque rupture, thrombus formation, ischemia and infarction. Novel therapeutic opportunities may emerge from understanding the role of inflammation in atherosclerosis...
Inflammation and atherosclerosisGoran K Hansson
Department of Medicine, Center for Molecular Medicine, Karolinska Institute, Stockholm SE 17176, Sweden
Annu Rev Pathol 1:297-329. 2006..Inflammatory markers are already used to monitor the disease process and anti-inflammatory therapy may be useful to control disease activity...
Vaccination against atherosclerosis? Induction of atheroprotective immunityGoran K Hansson
Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital L8 03, Stockholm, 17176, Sweden
Semin Immunopathol 31:95-101. 2009..This review summarizes our current understanding of the role immunity in atherosclerosis and outlines strategies for antigen-specific prevention of this disease...
The discovery of cellular immunity in the atherosclerotic plaqueGoran K Hansson
Karolinska Institutet, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 29:1714-7. 2009..This notion was met with general skepticism but has gained support from experimental and clinical studies. Here we describe some of the early studies that helped developing this concept...
Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wallD F J Ketelhuth
Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
Thromb Haemost 106:779-86. 2011..This review provides an overview of the research field of cellular immunity in atherosclerosis. It emphasises the events and findings involving antigen specific T cells, in particular low-density lipoprotein-specific T cells...
Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosisXinghua Zhou
Department of Medicine and Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Circ Res 96:427-34. 2005..These findings demonstrate complex roles of immune cell-cell interactions in the regulation of the atherosclerotic process and point to several possible targets in the treatment and prevention of atherosclerosis...
Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic miceXinghua Zhou
Centre for Molecular Medicine, Karolinska Institute, Stockholm, Sweden
Atherosclerosis 204:381-7. 2009..The present study was performed to investigate whether Th3 immune effector responses and their inducing cytokine, transforming growth factor-beta (TGF-beta) are affected by hypercholesterolemia...
Activation of VPAC1 receptors aggravates early atherosclerosis in hypercholesterolemic apolipoprotein E-deficient miceYuri Sheikine
Experimental Cardiovascular Research Unit, Center for Molecular Medicine, Department of Medicine at Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
Biochem Biophys Res Commun 402:471-6. 2010....
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) miceOlga Ovchinnikova
Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Am J Pathol 174:693-700. 2009..Our results suggest that exaggerated T-cell-driven inflammation limits collagen maturation in the atherosclerotic plaque while having little effect on collagen degradation...
Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarctionAnne Louise Hemdahl
Center for Molecular Medicine, Department of Medicine, Karolinska Hospital, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 26:136-42. 2006..This study aimed to analyze the expression of NGAL in atherosclerotic plaques and myocardial infarction (MI)...
T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic miceAriane Sultan
Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Circ Res 104:961-8. 2009..In conclusion, T-cell activation causes inflammation in adipose tissue but does not lead to insulin resistance in this tissue in the absence of interleukin-6...
Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosisXinghua Zhou
Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 26:864-70. 2006..We have previously shown that transfer of CD4+ T cells from apolipoprotein E knockout mice (apoE(-/-)) into immunodeficient apoE(-/-) scid/scid mice accelerates disease...
Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic miceAndreas Hermansson
Department of Medicine at Karolinska University Hospital Solna, Karolinska Institutet, Center for Molecular Medicine, Stockholm, Sweden
Circulation 123:1083-91. 2011..Atherosclerosis is a chronic inflammatory disease characterized by a massive intimal accumulation of low-density lipoprotein that triggers chronic vascular inflammation with an autoimmune response to low-density lipoprotein components...
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosisRoland Klingenberg
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 30:946-52. 2010..The objective of this study was to develop an atheroprotective vaccine by targeting a peptide of the LDL protein constituent apolipoprotein B-100 (apoB-100) to the nasal mucosa to induce a protective mucosal immune response...
Disruption of TGF-beta signaling in T cells accelerates atherosclerosisAnna Karin L Robertson
Center for Molecular Medicine, L8 03 Karolinska Hospital, SE 17176 Stockholm, Sweden
J Clin Invest 112:1342-50. 2003..Inhibition of T cell activation may therefore represent a strategy for antiatherosclerotic therapy...
Innate and adaptive immunity in the pathogenesis of atherosclerosisGoran K Hansson
Center for Molecular Medicine and Department of Medicine, Karolinska Institute, Stockholm, Sweden Goran Hansson cmm ki se
Circ Res 91:281-91. 2002..As we fill in the molecular details, new potential targets for therapies will doubtless emerge...
5-Lipoxygenase-activating protein: a potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammationMagnus Bäck
Department of Medicine, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Circ Res 100:946-9. 2007..In conclusion, the results of the present study suggest a key role for mediators of the 5-lipoxygenase pathway in inflammatory reactions of atherosclerosis and metabolic disease...
CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesionsDirk M Wuttge
Center for Molecular Medicine and the Department of Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 24:750-5. 2004..We investigated whether CXCL16 expression is controlled by interferon-gamma (IFN-gamma)-cytokine abundant in atherosclerotic lesions...
CD1d-dependent activation of NKT cells aggravates atherosclerosisEmmanuel Tupin
Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden
J Exp Med 199:417-22. 2004..Early activation of both T and B cells was followed by recruitment of T and NKT cells to the aorta and activation of inflammatory genes. These results show that activation of CD1d-restricted NKT cells exacerbates atherosclerosis...
Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humansNorbert Gerdes
Experimental Cardiovascular Research Unit at the Center for Molecular Medicine Solna, Karolinska Institute, Stockholm, Sweden
Thromb Haemost 106:353-62. 2011..Our study provides new insights into the cross-talk between thrombosis and adaptive immunity, and indicates that platelets can enhance T-effector cell development...
Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injuryAllan Sirsjo
Crafoord Laboratory of Experimental Surgery Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden
J Cardiovasc Pharmacol 41:897-902. 2003..14 and P < 0.01, respectively). Inhibition of NOS2 by two different approaches increased neointima formation in a mouse model of mechanical vessel injury, indicating that the NOS2 expressed in the injured vessel wall is beneficial...
CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic micePeder S Olofsson
Center for Molecular Medicine, L8 03, Karolinska University Hospital, Solna, 171 76 Stockholm, Sweden
Circulation 117:1292-301. 2008..Costimulatory molecules of the tumor necrosis factor superfamily such as CD40/CD40L and OX40/OX40L have been implicated in atherosclerosis...
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosisAndreas Hermansson
Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Stockholm SE 17176, Sweden
J Exp Med 207:1081-93. 2010....
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesionAnders Gabrielsen
Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
J Mol Med (Berl) 88:795-806. 2010..The findings suggest that intraplaque TXA(2) generation may contribute to the development of atherosclerosis and its thrombotic complications in humans...
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instabilityHong Qiu
Department of Medical Biochemistry and Biophysics, Division of Chemistry II, Karolinska Institutet, S 171 77 Stockholm, Sweden
Proc Natl Acad Sci U S A 103:8161-6. 2006..The abundant expression of LTA4H and correlation with plaque instability identify LTA4H as a potential target for pharmacological intervention in treatment of human atherosclerosis...
Inflammation, atherosclerosis, and coronary artery diseaseGoran K Hansson
Karolinska Institute, Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden
N Engl J Med 352:1685-95. 2005
Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardiumAnders Gabrielsen
Center for Molecular Medicine, Dept of Medicine, Experimental Cardiovascular Research, CMM L8 03, Karolinska Hospital, SE 17176, Stockholm, Sweden
J Mol Cell Cardiol 42:870-83. 2007..In addition, the findings support an important role of CTGF signalling in chronic extracellular matrix remodelling in chronic coronary artery disease...
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout miceRima Elhage
Department of Medicine at Karolinska Hospital and Center for Molecular Medicine L8 03, Karolinska Institute, SE 17176 Stockholm, Sweden
Cardiovasc Res 59:234-40. 2003..Nai;ve CD4+ T cells differentiate into interferon-gamma (IFN-gamma) producing Th1 effector cells when stimulated by interleukin-18 (IL-18) and IL-12. We wanted to directly test whether the Th1 pathway is proatherogenic...
Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) miceCharlotta Hjerpe
Centre for Molecular Medicine and Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Atherosclerosis 209:436-41. 2010..Dendritic cells (DCs), which are professional antigen-presenting cells that activate T cells, are present in atherosclerotic lesions but their role for atherosclerosis-related immunity is unclear...
Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomyLasse Folkersen
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
Mol Med 18:669-75. 2012..The method may be developed to identify subjects at very high risk of ischemic events...
Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief reportOlga Ovchinnikova
Department of Medicine, Center for Molecular Medicine, Stockholm, Sweden
Arterioscler Thromb Vasc Biol 29:1478-80. 2009..Osteoprotegerin (OPG) is a tumor necrosis factor receptor-related cytokine, initially found to inhibit osteoclastogenesis. In the present study we investigated the effect of OPG treatment on atherosclerosis...
Accumulation of foam cells in liver X receptor-deficient miceGertrud U Schuster
Department of Biosciences at Novum, Karolinska Institutet, Huddinge, Sweden
Circulation 106:1147-53. 2002..The present study aimed to elucidate the physiological relevance of both LXRs with regard to lipid metabolism and macrophage cholesterol efflux...
Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- miceAnne Louise Hemdahl
Department of Medicine, Karolinska Institute, SE 171 76, Stockholm, Sweden
Am J Physiol Heart Circ Physiol 287:H872-7. 2004..Exposure of atherosclerotic mice to hypoxia leads to myocardial infarction through a two-phase pathway in which acute transient ischemia is followed by thrombin-dependent, irreversible, myocardial ischemia and myocardial cell death...
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisRoland Klingenberg
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
J Clin Invest 123:1323-34. 2013..These results demonstrate that FOXP3(+) Tregs inhibit atherosclerosis by modulating lipoprotein metabolism...
The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic miceLei Zhang
Department of Medicine, Center for Molecular Medicine, L8 03, Karolinska University Hospital, Karolinska Institute, Stockholm SE 17176, Sweden
Eur Heart J 33:2025-34. 2012..The tryptophan metabolite 3-hydroxyanthranilic acid (3-HAA) has been shown to inhibit inflammation in different experimental autoimmune disease models. However, the effect of 3-HAA in atherosclerosis has never been explored...
The immune response in atherosclerosis: a double-edged swordGoran K Hansson
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, SE 17176, Sweden
Nat Rev Immunol 6:508-19. 2006..We also outline possible future targets for prevention, diagnosis and treatment of atherosclerosis...
Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ miceRoland Klingenberg
Experimental Cardiovascular Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Hospital, L8 03, SE 17176 Stockholm, Sweden
Immunobiology 217:540-7. 2012..To modulate atherosclerosis by combining subcutaneous immunization with heat shock protein 65 (hsp65) in alum adjuvant and anti-CD45RB monoclonal antibodies (mAb)...
Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblastsEdit Nagy
Center for Molecular Medicine, CMM L8 03, Karolinska University Hospital, Stockholm, Sweden
Circulation 123:1316-25. 2011..The aim of this study was to determine the role of proinflammatory signaling through the leukotriene (LT) pathway in aortic stenosis...
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responsesDaniel F J Ketelhuth
Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden
Circulation 124:2433-43, 1-7. 2011..In this study, we analyzed the proinflammatory activity of ApoB100 peptides in atherosclerosis...
Innate immunity, macrophage activation, and atherosclerosisZhong qun Yan
Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden
Immunol Rev 219:187-203. 2007..In its final section, we propose a model for the role of macrophages in bridging inflammation and atherosclerosis from the perspective of innate immune recognition and activation...
Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe(-/-) miceHanna E Agardh
Experimental Cardiovascular Research, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
J Cell Mol Med 17:303-10. 2013..The increased expression is primarily localized to neutrophils, but also in monocytes. We have identified FABP4 in leucocytes as a potential and easy accessible biomarker of atherosclerosis which could be of future clinical relevance...
Immunomodulation and vaccination for atherosclerosisXinghua Zhou
Center for Molecular Medicine and Department of Medicine, Karolinska Hospital, Stockholm, Sweden
Expert Opin Biol Ther 4:599-612. 2004..This review provides an overview of our current understanding of how immunomodulation changes the course of atherosclerosis and how vaccination may be used for preventing the disease...
12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptomsKarl Gertow
Department of Medicine, Center for Molecular Medicine, Unit of Experimental Cardiovascular Research, Karolinska Institutet, Stockholm SE 17176, Sweden
Atherosclerosis 215:411-6. 2011..These findings suggest a link between ALOX15B and atherothrombotic events that merits further investigation...
Leukotriene receptors in atherosclerosisMagnus Bäck
Department of Medicine, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden
Ann Med 38:493-502. 2006..Taken together, recent evidence suggests that leukotriene receptors may be a potential target in the treatment of atherosclerosis and in the prevention of restenosis after coronary interventions...
Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular diseaseLasse Folkersen
Atherosclerosis Research Unit, Experimental Cardiovascular Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Circ Cardiovasc Genet 3:365-73. 2010..Genes in close proximity to these risk-SNPs are often thought to be pathogenetically important based on their location alone. However, the actual connections between SNPs and disease mechanisms remain largely unknown...
Adaptive immunity and atherosclerosisJohn Andersson
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm SE 17176, Sweden
Clin Immunol 134:33-46. 2010..Furthermore, we outline future areas of research and potential clinical intervention strategies...
Immunomodulation of atherosclerosis: implications for vaccine developmentJan Nilsson
Department of Medicine, Malmo University Hospital, Lund University, Sweden
Arterioscler Thromb Vasc Biol 25:18-28. 2005..In this review, we summarize recent experimental studies using immunomodulatory approaches for treatment of atherosclerosis...
Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasiaMagnus Bäck
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
Proc Natl Acad Sci U S A 102:17501-6. 2005..Inhibition of LTB(4)/BLT(1) signaling during the response to vascular injury reduced intimal hyperplasia, suggesting this pathway as a possible target for therapy...
Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient miceRoland Klingenberg
Department of Cardiology, University Hospital Heidelberg, Germany
Arterioscler Thromb Vasc Biol 27:2392-9. 2007..The sphingolipid analogue drug FTY720 mediates retrafficking of immune cells and inhibits their homing to inflammatory sites. We have evaluated the effect of FTY720 on atherogenesis and lipid metabolism...
Innate immune signals in atherosclerosisAnna M Lundberg
Center for Molecular Medicine, L8 03, Department of Medicine, Karolinska Institute, Stockholm SE 17176, Sweden
Clin Immunol 134:5-24. 2010..In this review we describe the innate mechanisms present in the plaque. We focus on TLRs, their cross-talk with other PRRs, and how their signalling cascades influence inflammation within the atherosclerotic lesion...
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesionsPhan Kiet Tran
Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
Atherosclerosis 190:264-70. 2007..The study demonstrates a reduction of perlecan mRNA-expression and protein deposition in human atherosclerosis, which in part explains the low levels of heparan sulfate in this disease...
Vaccination and atherosclerosisXinghua Zhou
Center for Molecular Medicine L8 03, Karolinska Hospital, Karolinska Institutet, S 17176 Stockholm, Sweden
Curr Atheroscler Rep 6:158-64. 2004..This review provides an overview of our current understanding of effects and proposed mechanisms of immunization on preventing atherosclerosis...
Chemokines and atherosclerosisYuri Sheikine
Center for Molecular Medicine, Cardiovascular Research Unit, Karolinska Institute, Stockholm, Sweden
Ann Med 36:98-118. 2004..Modulation of chemokines and chemokine receptors' expression as well as their signaling pathways may provide important anti-atherogenic strategies...
Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaqueFei Chen
Crafoord Laboratory, South Hospital, Stockholm, Sweden
Int J Mol Med 15:57-65. 2005..Plasma MMP9 antigen was elevated in unstable patients. MMP9 is expressed in the unstable coronary atherosclerotic plaque, as are its transcriptional and posttranscriptional regulators...
The immune system in atherosclerosisGoran K Hansson
Center for Molecular Medicine, Department of Medicine, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden
Nat Immunol 12:204-12. 2011..Studies are now under way to develop new therapies based on these concepts of the involvement of the immune system in atherosclerosis...
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarctionKristina Edfeldt
Experimental Cardiovascular Research Unit, Center for Molecular Medicine, Karolinska Institute, Stockholm, Sweden
Eur Heart J 25:1447-53. 2004..Recent studies imply that TLR4 polymorphisms might affect atherogenesis. In this study we investigated the impact of LPS-hypo-responsive TLR4 variants on the risk of myocardial infarction (MI)...
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic miceGiuseppina Caligiuri
Center for Molecular Medicine and Department of Medicine, Karolinska Institute, SE 171 76 Stockholm, Sweden
J Clin Invest 109:745-53. 2002..These results demonstrate that B cell-associated protective immunity develops during atherosclerosis and reduces disease progression...
